662 related articles for article (PubMed ID: 24962722)
1. Intranasal formulations: promising strategy to deliver vaccines.
Riese P; Sakthivel P; Trittel S; Guzmán CA
Expert Opin Drug Deliv; 2014 Oct; 11(10):1619-34. PubMed ID: 24962722
[TBL] [Abstract][Full Text] [Related]
2. Nasal and pulmonary vaccine delivery using particulate carriers.
Jia Y; Krishnan L; Omri A
Expert Opin Drug Deliv; 2015 Jun; 12(6):993-1008. PubMed ID: 25952104
[TBL] [Abstract][Full Text] [Related]
3. Synthetic polyacrylate polymers as particulate intranasal vaccine delivery systems for the induction of mucosal immune response.
Zaman M; Simerska P; Toth I
Curr Drug Deliv; 2010 Apr; 7(2):118-24. PubMed ID: 20158484
[TBL] [Abstract][Full Text] [Related]
4. Chitosan-based delivery systems for mucosal vaccines.
Jabbal-Gill I; Watts P; Smith A
Expert Opin Drug Deliv; 2012 Sep; 9(9):1051-67. PubMed ID: 22708875
[TBL] [Abstract][Full Text] [Related]
5. New strategies for using mucosal vaccination to achieve more effective immunization.
Walker RI
Vaccine; 1994 Apr; 12(5):387-400. PubMed ID: 8023545
[TBL] [Abstract][Full Text] [Related]
6. Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines.
Vajdy M; Srivastava I; Polo J; Donnelly J; O'Hagan D; Singh M
Immunol Cell Biol; 2004 Dec; 82(6):617-27. PubMed ID: 15550120
[TBL] [Abstract][Full Text] [Related]
7. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
De Magistris MT
Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
[TBL] [Abstract][Full Text] [Related]
8. Subunit-based mucosal vaccine delivery systems for pulmonary delivery - Are they feasible?
Marasini N; Kaminskas LM
Drug Dev Ind Pharm; 2019 Jun; 45(6):882-894. PubMed ID: 30767591
[TBL] [Abstract][Full Text] [Related]
9. Nasal vaccine innovation.
Jabbal-Gill I
J Drug Target; 2010 Dec; 18(10):771-86. PubMed ID: 21047271
[TBL] [Abstract][Full Text] [Related]
10. Delivery systems: a vaccine strategy for overcoming mucosal tolerance?
Mann JF; Acevedo R; Campo JD; Pérez O; Ferro VA
Expert Rev Vaccines; 2009 Jan; 8(1):103-12. PubMed ID: 19093777
[TBL] [Abstract][Full Text] [Related]
11. Intranasal delivery of nanoparticle-based vaccines.
Marasini N; Skwarczynski M; Toth I
Ther Deliv; 2017 Jan; 8(3):151-167. PubMed ID: 28145824
[TBL] [Abstract][Full Text] [Related]
12. Rational design of nasal vaccines.
Slütter B; Hagenaars N; Jiskoot W
J Drug Target; 2008 Jan; 16(1):1-17. PubMed ID: 18172815
[TBL] [Abstract][Full Text] [Related]
13. Novel vaccine development strategies for inducing mucosal immunity.
Fujkuyama Y; Tokuhara D; Kataoka K; Gilbert RS; McGhee JR; Yuki Y; Kiyono H; Fujihashi K
Expert Rev Vaccines; 2012 Mar; 11(3):367-79. PubMed ID: 22380827
[TBL] [Abstract][Full Text] [Related]
14. Solid-in-oil nanodispersions for intranasal vaccination: Enhancement of mucosal and systemic immune responses.
Kong Q; Kitaoka M; Tahara Y; Wakabayashi R; Kamiya N; Goto M
Int J Pharm; 2019 Dec; 572():118777. PubMed ID: 31678377
[TBL] [Abstract][Full Text] [Related]
15. Attenuated Bordetella pertussis BPZE1 as a live vehicle for heterologous vaccine antigens delivery through the nasal route.
Li R; Lim A; Alonso S
Bioeng Bugs; 2011; 2(6):315-9. PubMed ID: 22067832
[TBL] [Abstract][Full Text] [Related]
16. Nasal route for vaccine and drug delivery: Features and current opportunities.
Lobaina Mato Y
Int J Pharm; 2019 Dec; 572():118813. PubMed ID: 31678521
[TBL] [Abstract][Full Text] [Related]
17. Nanotechnology solutions for mucosal immunization.
Chadwick S; Kriegel C; Amiji M
Adv Drug Deliv Rev; 2010 Mar; 62(4-5):394-407. PubMed ID: 19931581
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticles for nasal vaccination.
Csaba N; Garcia-Fuentes M; Alonso MJ
Adv Drug Deliv Rev; 2009 Feb; 61(2):140-57. PubMed ID: 19121350
[TBL] [Abstract][Full Text] [Related]
19. Dry powder vaccines for mucosal administration: critical factors in manufacture and delivery.
Wang SH; Thompson AL; Hickey AJ; Staats HF
Curr Top Microbiol Immunol; 2012; 354():121-56. PubMed ID: 21822816
[TBL] [Abstract][Full Text] [Related]
20. Mucosal immunisation: adjuvants and delivery systems.
Moyle PM; McGeary RP; Blanchfield JT; Toth I
Curr Drug Deliv; 2004 Oct; 1(4):385-96. PubMed ID: 16305400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]